Pathalys Pharma
Clinical trials sponsored by Pathalys Pharma, explained in plain language.
-
New hope for dialysis patients with common hormone imbalance
Disease control CompletedThis study tested whether a drug called PLS240 could safely and effectively treat a hormone disorder called secondary hyperparathyroidism in people with kidney failure who are on dialysis. For the first 27 weeks, 412 participants were randomly assigned to receive either the drug …
Phase: PHASE3 • Sponsor: Pathalys Pharma • Aim: Disease control
Last updated Apr 04, 2026 06:50 UTC
-
New hope for dialysis patients: drug aims to tame dangerous hormone imbalance
Disease control CompletedThis study tested a drug called PLS240 for people with end-stage kidney disease on dialysis who also have a hormone imbalance called secondary hyperparathyroidism. The goal was to see if PLS240 could safely and effectively lower high levels of a specific hormone. In the first par…
Phase: PHASE3 • Sponsor: Pathalys Pharma • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC